Results 101 to 110 of about 2,062,274 (306)
Archives of Medicine and Health Sciences, 2015 Background: Oral candidiasis is increasingly seen among hospitalized patients and is usually treated empirically. It can be the marker of systemic infection. Antifingal resistance is one of the emerging problems in candidiasis.
Faseela Taivalap Shafi +2 more
doaj +1 more source
Epidemiology of mixed vaginitis and its management [PDF]
, 2013 Vaginitis is a common reason for visits to a health care provider, accounting for 6 million visits per year. Symptoms associated with vaginitis can cause substantial distress, resulting in time lost from work and altered self-esteem.
Galea, Therese
core
Allergy, EarlyView.ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
T. Zuberbier +221 more
wiley +1 more source
Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up. [PDF]
, 2012 Article approval pendingAntiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the ...
Bisson +30 more
core +2 more sources
Therapeutic tools for oral candidiasis: Current and new antifungal drugs
Medicina Oral, 2019 Background Candidiasis is one of the most common opportunistic oral infections that presents different acute and chronic clinical presentations with diverse diagnostic and therapeutic approaches.
G. Quindós +6 more
semanticscholar +1 more source
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.In a pilot randomized clinical trial of cesarean‐born infants, vaginal microbiota transfer improved social–emotional development at 12 months, reducing social–emotional risk and improving key subdomains, while early neurodevelopmental benefits observed at 6 months were not sustained at 12 months. Abstract Introduction To evaluate the effects of vaginal
Chuhui Zhou +9 more
wiley +1 more source
Saudi Journal of Oral Sciences, 2019 Background: Change in the distribution profile of nonalbicans Candida species (spp.) can be an indication of immunosuppression or drug resistance to oral candidiasis in patients with human immunodeficiency virus (HIV).
Varun Nair, Arvind Shetti
doaj +1 more source
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu +3 more
wiley +1 more source
Community Dentistry and Oral Epidemiology, EarlyView.ABSTRACT Objectives The objective of this scoping review was to map existing literature on oral health and related care in individuals with Motor Neurone Disease (MND). Specifically, the review aimed to identify barriers and facilitators to maintaining oral hygiene, summarise available clinical guidelines and patient‐facing resources, and examine how ...
Mariam A. Khokhar +3 more
wiley +1 more source
Vaginal yeasts in the era of "over the counter" antifungals [PDF]
, 2000 OBJECTIVE: To establish whether there has been any rise in the prevalence of non-albicans Candida species isolated from vaginal swabs since the introduction of “over the counter” antifungal treatments.
Ashbee, H.R. +4 more
core +2 more sources